2019, Number 5
Surgical treatment of benign prostatic hyperplasia: A literature review
Language: Spanish
References: 62
Page: 1-18
PDF size: 400.75 Kb.
ABSTRACT
Background: Benign prostatic hyperplasia is a prevalent pathology. The need for medical or surgical treatment depends on the severity of the lower urinary tract symptoms. The gold standard for surgical treatment is bipolar transurethral resection of the prostate (B-TURP).Objective: To evaluate the different surgical techniques, comparing their efficacy and safety in the treatment of benign prostatic hyperplasia.
Methods: A narrative review of the literature was carried out through a search of five databases: PubMed, Embase, Lilacs, Science Direct, and GreyNet. Meta- analyses, systematic reviews, and randomized clinical trials published from 2006 to 2016 were evaluated to determine the efficacy and safety of the surgical techniques for the treatment of benign prostatic hyperplasia.
Results: A total of 2505 articles were selected by title and abstract and the complete texts of 94 of those articles were reviewed. The different surgical techniques encountered were monopolar TURP, bipolar TURP, open prostatectomy, plasma vaporization, laser techniques, and minimally invasive ablation techniques. The majority of the articles compared bipolar turp (the gold standard) vs other surgical methods, focusing on clinical outcomes based on the IPSS, QMAX, PVR, and QOL instruments. The results were similar among all the techniques.
Conclusions: Bipolar TURP is the most widely practiced technique for benign prostatic hyperplasia management and has good results, compared with monopolar turp. Results are similar between the bipolar turp, holep, thulep, Greenlight laser, and TUMT modalities. The choice of surgical technique is dependent on the expertise of the surgeon and the characteristics of each patient. The results of the present review are heterogeneous, making further study necessary.
REFERENCES
Cornu J-N, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2015 Jun;67(6):1066–96. doi: https://doi.org/10.1016/j.eururo.2014.06.017
Hoekstra RJ, Melick HHEV, Kok ET, Bosch JLHR. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; longterm results of a randomized controlled trial. British Journal of Urology International. 2010 Sep;106(6):822–6. doi: https://doi. org/10.1111/j.1464-410X.2010.09229.x
Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, et al. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012 Jan;109(2):240– 8. doi: https://doi.org/10.1111/j.1464- 410X.2011.10222.x
Yee C, Wong JH, Chiu PK, Chan C, Lee W, Tsu JH, et al. Short-stay transurethral prostate surgery: A randomized controlled trial comparing transurethral resection in saline bipolar transurethral vaporization of the prostate with monopolar transurethral resection. Asian J Endosc Surg. 2015 Aug;8(3):316–22. doi: https://doi.org/10.1111/ases.12197
Xie J, Tan Y, Wang F, Xuan Q, Sun Y, Xiao J, et al. Extraperitoneal laparoscopic adenomectomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and functional outcomes after 3-year follow-up. J Endourol. 2014 Mar;28(3):353–9. doi: https:// doi.org/10.1089/end.2013.0374
Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol. 2016 Jan;69(1):94–102. doi: https://doi.org/10.1016/j.eururo.2015.07.054
Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570–8. doi: https://doi.org/10.1016/j.juro.2014.09.001
Elshal AM, Elkoushy MA, El-Nahas AR, Shoma AM, Nabeeh A, Carrier S, et al. GreenLightTM laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol. 2015 Mar;193(3):927–34. doi: https://doi.org/10.1016/j.juro.2014.09.097
Telli O, Okutucu TM, Suer E, Burgu B, Gulpinar O, Yaman O, et al. A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc. Ther Adv Urol. 2015 Feb;7(1):3–8. doi: https://doi. org/10.1177/1756287214556643
Lukacs B, Loeffler J, Bruyère F, Blanchet P, Gelet A, Coloby P, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012 Jun;61(6):1165–73. doi: https://doi. org/10.1016/j.eururo.2012.01.052
Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011 Oct;60(4):734–9. doi: https://doi. org/10.1016/j.eururo.2011.05.043
Pereira-Correia JA, de Moraes Sousa KD, Santos JBP, de Morais Perpétuo D, Lopesda- Silva LF, Krambeck RL, et al. GreenLight HPSTM 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012 Oct;110(8):1184–9. doi: https://doi. org/10.1111/j.1464-410X.2011.10878.x
Skolarikos A, Papachristou C, Athanasiadis G, Chalikopoulos D, Deliveliotis C, Alivizatos G. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol. 2008 Oct;22(10):2333– 40. doi: https://doi.org/10.1089/end.2008.9709
Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective Potassium Titanyl Phosphate (KTP) Laser Vaporization Versus Transurethral Resection of the Prostate for Prostates Larger Than 70 mL: A Short- Term Prospective Randomized Trial. Urology. 2008 Feb 1;71(2):247–51. doi: https://doi. org/10.1016/j.urology.2007.09.017
Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassiumtitanyl- phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010 Apr;105(7):964–9. doi: https://doi. org/10.1111/j.1464-410X.2009.08961.x
Wu G, Hong Z, Li C, Bian C, Huang S, Wu D. A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up. Lasers Med Sci. 2016 May;31(4):599–604. doi: https://doi. org/10.1007/s10103-016-1883-1
Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A. Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology. 2014 Sep;84(3):526–32. doi: https:// doi.org/10.1016/j.urology.2014.05.027
Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006 Sep;50(3):569– 73. doi: https://doi.org/10.1016/j. eururo.2006.04.002
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Longterm results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012 Feb;109(3):408– 11. doi: https://doi.org/10.1111/j.1464- 410X.2011.10359.x
Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F, et al. A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol. 2014 Jun;32(3):683–9. doi: https://doi. org/10.1007/s00345-013-1103-6
Yan H, Ou T-W, Chen L, Wang Q, Lan F, Shen P, et al. Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol. 2013 May;20(5):507–12. doi: https://doi. org/10.1111/j.1442-2042.2012.03183.x
Luo Y-H, Shen J-H, Guan R-Y, Li H, Wang J. Plasmakinetic enucleation of the prostate vs plasmakinetic resection of the prostate for benign prostatic hyperplasia: comparison of outcomes according to prostate size in 310 patients. Urology. 2014 Oct;84(4):904–10. doi: https://doi.org/10.1016/j.urology.2014.06.025
Chen S, Zhu L, Cai J, Zheng Z, Ge R, Wu M, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol. 2014 Aug;66(2):284–91. doi: https://doi. org/10.1016/j.eururo.2014.01.010
Zhao Z, Zeng G, Zhong W, Mai Z, Zeng S, Tao X. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol. 2010 Nov;58(5):752–8. doi: https://doi. org/10.1016/j.eururo.2010.08.026
Mattiasson A, Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology. 2007 Jan;69(1):91–6; discussion 96-97. doi: https:// doi.org/10.1016/j.urology.2006.08.1115
Schelin S, Geertsen U, Walter S, Spångberg A, Duelund-Jacobsen J, Krøyer K, et al. Feedback microwave thermotherapy versus TURP/ prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study. Urology. 2006 Oct;68(4):795–9. doi: https://doi. org/10.1016/j.urology.2006.05.020
Shore ND, Sethi PS. A controlled, randomized, head-to-head comparison of the Prolieve thermodilatation System versus the Targis System for benign prostatic hyperplasia: safety, procedural tolerability, and clinical results. J Endourol. 2010 Sep;24(9):1469–75. doi: https://doi.org/10.1089/end.2009.0416
Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, et al. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014 Apr;113(4):615–22. doi: https://doi. org/10.1111/bju.12540